Director/PDMR Shareholding

By

Regulatory News | 12 Aug, 2019

Updated : 16:30

RNS Number : 7732I
Consort Medical PLC
12 August 2019
 

Consort Medical plc

Director Shareholding

12 August 2019

Consort Medical plc (the 'Company') announces that Ian Nicholson, Non-executive director, purchased 1,350 ordinary 10p shares at a price of £7.36 per share on 9 August 2019. Following this transaction Mr Nicholson holds 2,362 ordinary shares in the Company.

The Notification of Dealing Form set out below is provided in accordance with the requirements of the Market Abuse Regulation.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Ian Nicholson

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Non-Executive Director

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Consort Medical plc

 

b)

 

LEI

 

 

2138001TBP74FD66QT38

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 10p each



Identification code

ISIN: GB0000946276



b)

 

Nature of the transaction

 

 

Acquisition

c)

 

Price(s) and volume(s)

 

 

 

 


 

Price(s)

Volume(s)

 


 

£7.36

1,350

 


 

 

 

 

d)

 

Aggregated information




- Aggregated volume




- Price




e)

 

Date of the transaction

 

 

2019-08-09

f)

 

Place of the transaction

 

 

NEX Trading Equity (NEXT)

 

Enquiries:  Andrew Jackson, Company Secretary 01442 867920


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHELLFFKVFLBBV

Last news